Jesús Jonathan García-Galindo

9PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersNutrigenomics and personalised nutritionFood properties (incl. characteristics and health benefits)Metabolic medicineGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2026
Bidirectional Interactions Between Cervicovaginal Microbiota and Human Papillomavirus Drive Persistence and Disease Progression.

|May 04, 2026
Biomarkers and Endothelial Damage in Obesity: An Insight into the Pharmacological Modulation.

|Mar 28, 2026
The Gut Microbiota in Parkinson's Disease: Mechanistic Insights into Microbial-Host Interactions.

Luis Enrique Guerrero-Torres, Jesús Jonathan García-Galindo, María Fernanda Gómez-Galindo

|Feb 13, 2026
Enteric Infections, Dysbiosis, and Metabolic Dysfunction: The Role of Diarrheagenic Pathogens in Insulin Resistance.

Martin Zermeño-Ruiz, Filiberto Gutierrez-Gutierrez, Elsa Janneth Anaya-Ambriz

|Feb 26, 2025
Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders.

Emiliano Peña-Durán, Jesús Jonathan García-Galindo, Luis Daniel López-Murillo

|Oct 25, 2024
Correction: Balleza Alejandri et al. Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial. J. Cardiovasc. Dev. Dis. 2024, 11, 182.

Luis Ricardo Balleza Alejandri, Fernando Grover Páez, Erick González Campos

Pageof 2

Frequent Collaborators

8 joint publications

Alberto Beltrán-Ramírez

8 joint publications

Daniel Osmar Suárez-Rico

6 joint publications

Luis Ricardo Balleza-Alejandri

3 joint publications

Emiliano Peña-Durán